Cargando…
Effects of 4-methylimidazole on cerebral glutamate decarboxylase activity and specific GABA receptor binding in mice
4-Methylimidazole (4MeI) is a tremorogenic and convulsive agent of concern both in human and veterinary toxicology. The in vitro effects of 4MeI (5 μM–20 mM) on cerebral glutamate decarboxylase (GAD) activity and (in concentrations up to 50 mM) on binding of [(3)H]GABA to cerebral GABA receptors wer...
Autores principales: | Sivertsen, Tore, Nygaard, Ann-Kristin, Mathisen, Gro, Fonnum, Frode |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736537/ https://www.ncbi.nlm.nih.gov/pubmed/19730755 http://dx.doi.org/10.1080/15376510802488173 |
Ejemplares similares
-
Calpain Cleavage of Brain Glutamic Acid Decarboxylase 65 Is Pathological and Impairs GABA Neurotransmission
por: Buddhala, Chandana, et al.
Publicado: (2012) -
Glutamate Decarboxylase from Lactic Acid Bacteria—A Key Enzyme in GABA Synthesis
por: Yogeswara, Ida Bagus Agung, et al.
Publicado: (2020) -
Overexpression of Glutamate Decarboxylase in Mesenchymal Stem Cells Enhances Their Immunosuppressive Properties and Increases GABA and Nitric Oxide Levels
por: Urrutia, Mariana, et al.
Publicado: (2016) -
Production of γ-Aminobutyrate
(GABA)
in Recombinant Corynebacterium glutamicum by Expression of Glutamate Decarboxylase Active at Neutral pH
por: Son, Jina, et al.
Publicado: (2022) -
Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes
Publicado: (1995)